Immunogenicity and safety of BNT162b2 mRNA vaccine booster in actively treated patients with cancer

Hagai Ligumsky(Tel Aviv University), Herut Dor(Tel Aviv University), Tal Etan(Tel Aviv Sourasky Medical Center), Inbal Golomb(Tel Aviv University), Alla Nikolaevski‐Berlin(Tel Aviv Sourasky Medical Center), Inbal Greenberg(Tel Aviv University), Tamar Halperin(Tel Aviv Sourasky Medical Center), Yoel Angel(Tel Aviv University), Oryan Henig(Tel Aviv Sourasky Medical Center), Avishay Spitzer(Weizmann Institute of Science), Marina Slobodkin(Tel Aviv Sourasky Medical Center), Ido Wolf(Tel Aviv University)
The Lancet Oncology
December 23, 2021
Cited by 41Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis